Enhance Therapies' Unattributed Round

Enhance Therapies raised a round of funding on , . Investors include Elevate Ventures.

Enhance is developing a technology that seeks to become a best-in-class surgical guided imaging agent for bladder cancer and subsequent monitoring of patients post-surgery.…

Articles about Enhance Therapies' Unattributed Round: